Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

The Benefit of Short-Term Weight Loss with Anti-Obesity Medications in Real-World Clinical Practice

Abstract

Objective: The effectiveness of anti-obesity medications (AOMs) outside of clinical trials is unclear. The objective of this study was to compare the short-term effectiveness of AOMs in real-world practice. Methods: This retrospective study included adults aged ≥18 years, with body mass index ≥30 kg/m 2 or ≥27 kg/m 2 with at least one obesity-related comorbidity who were prescribed phentermine hydrochloride, phenterminetopiramate, bupropion-naltrexone, or lorcaserin for 12 consecutive weeks between 2006 and 2016 at a large tertiary healthcare system. Propensity score-matched cohorts were created for each pair of AOMs. The primary outcomes were percent and absolute weight loss from baseline after 12 weeks. A prediction model was constructed to estimate weight loss with different AOMs based on demographic and clinical data. Results: Of the 3,411 patients included in this study, patients lost an average of 3.45% of body weight from baseline. All AOMs were associated with a significant weight loss from baseline ( P Conclusion: In real-world practice, AOMs are associated with clinically meaningful weight loss of 2 to 4% after 12 weeks. In this study, phentermine hydrochloride and phentermine topiramate produced the most weight loss. AOMs should be seriously considered as part of the armamentarium to treat patients with obesity. Abbreviations: AOM = anti-obesity medication; BMI = body mass index; EMR = electronic medical record; FDA = Food and Drug Administration; T2D = type 2 diab…

Overview

Integrity signals

Registry

Crossref · 10.4158/ep-2019-0081

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 22 · Cited by 27

Metadata

Authors
Shibuya, K., Ali, K. F., Ji, X., Milinoivh, A., Bauman, J., Kattan, M. W., Pantalone, K. M., & Burguera, B.
Affiliations
  • Cleveland Clinic Lerner College of Medicine (US)
  • Cleveland Clinic (US)
Corresponding author
Burguera, Bartolome
Venue
Endocrine Practice
Publisher
Elsevier BV
Published
2019-10
Volume
25
Issue
10
Pages
1022-1028
ISSN
1530-891X (ISSN-L)
OpenAlex
W2953705715
Cited by
27
References
22
Citations by year
2026: 2 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 10
FWCI
2.79
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • Endocrine Practice (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
Keywords
anti-obesity drugs, short-term weight loss, phentermine/topiramate, naltrexone/bupropion, lorcaserin, obesity, obesity-related comorbidities, real-world effectiveness, propensity score matching
MeSH terms
Topiramate, Adult, Diabetes Mellitus, Type 2, Fructose, Humans, Obesity, Retrospective Studies, Weight Loss, Anti-Obesity Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Benefit of Short-Term Weight Loss with Anti-Obesity Medications in Real-World Clinical Practice. https://app.cochat.ai/papers/10.4158/ep-2019-0081
The paper
Shibuya, K., Ali, K. F., Ji, X., Milinoivh, A., Bauman, J., Kattan, M. W., Pantalone, K. M., & Burguera, B. (2019). The Benefit of Short-Term Weight Loss with Anti-Obesity Medications in Real-World Clinical Practice. Endocrine Practice. https://doi.org/10.4158/ep-2019-0081

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.